[Novel aspects of pathogenesis of hereditary hemochromatosis]

Area of Science:

• Genetics and Molecular Biology
• Hematology
• Internal Medicine

Background:

• Hereditary hemochromatosis (HC) presents diverse clinical symptoms, complicating diagnosis and specialist referral.
• The genetic basis of HC is more complex than initially understood, with the HFE gene and its mutations (C282Y, H63D) identified in 1996.
• While HFE mutations are common, non-HFE forms of hemochromatosis exist, highlighting the need for broader genetic investigation.

Purpose of the Study:

• To explore the complex molecular basis of hereditary hemochromatosis.
• To review the discovery of genes involved in iron homeostasis beyond HFE.
• To understand the role of hepcidin and other proteins in iron regulation and disease classification.

Main Methods:

• Literature review of genetic studies on hereditary hemochromatosis.
• Analysis of gene identification and functional studies related to iron homeostasis.
• Examination of population genetics data for HFE mutations.

Main Results:

• Identification of HFE gene mutations (C282Y, H63D) and their population frequency.
• Discovery of additional genes involved in iron homeostasis: hepcidin (HAMP), hemojuvelin (HJV), transferrin receptor 2 (TfR2), and ferroportin.
• Elucidation of hepcidin's central role in iron mobilization and regulation by HFE, TfR2, and HJV.
• Demonstration of HAMP's negative regulation of cellular iron efflux via ferroportin.

Conclusions:

• Hereditary hemochromatosis encompasses multiple genetic types, including non-HFE forms.
• Hepcidin is a key regulator of iron homeostasis, influenced by several other genes.
• Ongoing research suggests potential digenic inheritance or modifier gene involvement.
• The OMIM classification now includes four types of hereditary hemochromatosis based on these investigations.